High on Health: CBD in the Food Supply

Allan Badiner

Endocannabinoids are naturally occurring compounds found in the human body. They’ve been there for 600,000 years or more, but we’ve only just noticed them!

One of the remarkable things about endocannabinoids is their striking similarity to the active ingredients of cannabis called phyto-cannabinoids.

In fact, it was the effort by scientists to understand the exact mechanism by which cannabis works in the body that led to the discovery of the endocannabinoid system little more than a decade ago.

The science of endocannabinoid medicine has progressed to a dizzying degree in the past few years. There is wider awareness that the endocannabinoid system is the largest neurotransmitter system in the human body, regulating relaxation, eating, sleeping, memory, and, as noted by Italian scientist Vincenzo Di Marzo, even our immune system.

Cannabinoids promote homeostasis, the maintenance of a stable internal environment despite external fluctuations, at every level of biological life, from the subcellular to the organism.

For example, endocannabinoids are now understood as the source of runner’s high. Endocannabinoids naturally found in human breast milk, which are vital for proper human development, have virtually identical effects as cannabinoids found in the cannabis plant.

Amazingly, the mechanism at work after smoking or eating cannabis, when adults get the “munchies,” is essentially the same as what causes breastfeeding babies to seek protein-rich milk.

Universally accepted following its discovery in 1995, the endocannabinoid system asserts it power to heal and balance the other systems of the body by turning on or off the expression of genes.

Cannabinoids hold the key that unlocks receptor sites throughout the brain and immune system, triggering potent healing and painkilling effects.

The endocannabinoid anandamide (Ananda = bliss in Sanskrit + amide = chemical type), a naturally neurotransmitting lipid compound made by all mammals, is basically a self-manufactured “natural THC” circulating within. Anandamide and THC act through the cannabinoid receptors and have similar effects on pain, appetite, and memory.

There are two types of cannabinoid receptors in the body: CB1 receptors found primarily in the brain and central nervous system and CB2 receptors that are distributed but primarily found in the immune system. These receptors respond to cannabinoids, whether from breast milk or a cannabis plant.

Aside from the cannabinoids produced by the body and those found in cannabis, there are numerous substances that interact with the endocannabinoid system, such as cacao, black pepper, echinacea, turmeric, and even carrots.

But it is the Cannabis plant that produces the most powerful cannabinoids mimicking most closely those produced by the body. No downsides, no side effects, no drug interaction issues, and so far, no giving up your hard-earned funds to Big Pharma.

Make no mistake: I’m not referring to THC, of which Americans smoke more per person than any other people on Earth, but rather the other, non-psychoactive cannabinoid called Cannabidiol (CBD), a prominent molecular component of the cannabis plant.

While CBD does not bind to either CB1 or CB2 cannabinoid receptors directly, it does stimulate endogenous cannabinoid activity by suppressing an enzyme that breaks down anandamide.

CBD is also a counterbalance to the action of THC at the CB1 receptor, mitigating or muting the psychoactive effects of THC. Weed enthusiasts would be wise to keep some CBD on hand for when things get … out of hand.

If just ten percent of what researchers are now saying about CBD is true, then this is a discovery with significance similar in medical impact to the discovery of antibiotics.

Myriad scientific, peer-reviewed studies in Europe have pointed to CBD as having almost unprecedented healing power over an extraordinary variety of pathologies. Even the stodgy National Cancer Institute has referenced this on their website.

Surprisingly, there is still little awareness of this outside of the medical research community. Surely an unknown plant newly found in a remote rainforest with the same medical profile would be heralded as a miraculous cure. But in the last half-century, this particular plant has been better known as an intoxicant than a medicine.

The stigma that obscures wider awareness of its beneficial nature has been carefully cultivated. For decades, Hearst newspapers bombarded Americans with images of Mexicans and African Americans led into vice and violence by the “evil weed.”

In the public mind, cannabis was transformed from an obscure ingredient in patented medicines with pharmacy sales rivaling aspirin, to an intoxicant the use of which would lead inevitably to decline and debauchery.

In a spectacular confluence of politics, racism, corporate greed and political corruption, the federal government managed to outlaw cannabis for all purposes in 1937, with medical research becoming virtually impossible in the US.

Now, in California and around the country, research doctors are peer-reviewing the recent explosion of clinical studies from abroad, as well as conducting their own preclinical research without humans.

Persuasive evidence abounds that CBD is effective in easing symptoms of as well as reversing a wide range of difficult-to-control conditions, including: rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy.

CBD has no side effects and becomes very effective as an antipsychotic when given in larger doses. With more antioxidant potency than either vitamin C or E, CBD has consistently demonstrated neuroprotective effects, and its anti-cancer potential is, by all accounts, enormous.

Sean McAllister, PhD, of California Pacific Medical Center, said, “CBD could spell the end of breast cancer” and claims it could render chemotherapy and radiation distant second and third options for cancer patients.

Don Abrams, MD, at UCSF says the studies point to “a remarkable ability of CBD to arrest cancer cell division, cell migration, metastasis, and invasiveness.”

The vast impact of the endocannabinoid system on human health explains and validates anecdotal reports of cannabis used effectively for a wide range of health conditions.

Studies on the efficacy of CBD treatment are already driving the design and development of precision-targeted, single-molecule medicines. Indeed, we are hard-wired for cannabinoids.

The US government may not admit the medical efficacy of cannabis, but the global pharmaceutical industry has been researching it for many years.

Some three hundred and fifty scientists from drug company labs, including those of Merck, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca and Allergan (maker of Botox and silicone breast implants), regularly attend meetings of the International Cannabinoid Research Society.

They are all trying to develop synthetic drugs that confer some of the health benefits of cannabis without the psychoactivity. “It’s a foregone conclusion,” says Julie Holland, MD, “that the next decade will see a new generation of Big Pharma medications based on cannabis.”

According to Martin A. Lee, author of SMOKE SIGNALS, vitamin D combined with CBD could become “the killer public health app of the post-prohibition era.”

A new CBD/THC medicine for cancer pain called Sativex from the British company, GW Pharmaceuticals, is finishing the FDA’s final approval process.

While there is no time limit on enduring prejudice, as science reveals more about how the cannabinoid system works, the stigma associated with cannabis use is expected to fade.

CBD-enriched health foods, tinctures and oils are the next revolution in food and medicine. There is currently an explosion of entrepreneurial activity and creativity around making up for lost time with CBD.

LA-based cannabis physician Allan Frankel explains that “up until this past year, it has been impossible to help patients using CBD. Cannabis growers were focused on the stoniest weed.”

Hence, CBD, which is non-psychoactive, was nearly lost. Now, more CBD-rich strains are turning up, in part because there are laboratories that can accurately assess how much of which cannabinoid is present and check for mold and pesticides.

We are still in the early stages of understanding the synergistic effects of all the cannabinoids, not to mention the terpenoids—the sticky, aromatic terpenes that give cannabis its characteristic smell.

Research, as well as results in the field, shows that the presence of some THC and other cannabinoids in smaller amounts potentiates the healing effects of CBD.

The combined effect of cannabinoids, terpenes and perhaps another two hundred molecules all working together and carefully balanced in nature is what Dr. Ethan Russo calls an “Entourage Effect.”

The burgeoning edible cannabis industry until recently was focused on making food items so radically THC-dominant that you could easily become catatonic three hours after ingestion.

Anecdotal evidence suggests that while most people enjoy these powerful treats, many people have had challenging experiences, replete with anxiety, panic, and functional psychosis.

Fortunately, for seekers of good health or for those targeting disease, there are now CBD-rich edibles that don’t make you high, such as raw organic cacao from the Green Cacao Company, multi-flavored, CBD-dominant lozenges, and other similar products delightful to the palate as well as therapeutically effective.

As the health benefits are better understood, the huge market potential of non-psychoactive CBD foods will likely be recognized. CBD-rich tinctures, such as those from Denver-based Dixie Botanicals, are available over the Internet with no medical marijuana permit required.

Before long, there will be a plethora of food products rich in CBD, essentially creating a new food sector more legitimately called “health food” than what is currently found in natural foods stores.

CBD-rich foods need not make any health claims, thus avoiding issues with the FDA. Imagine creamy CBD-enhanced peanut butter, cooking oils, cereals, and beverages.

Don’t be surprised if in a few short years, you hear doctors (not just cannabis physicians) advise their patients to “exercise and get your CBD.” Obtaining enough CBD to make a medically significant difference requires edible, vapor or sublingual delivery, eliminating the health risks associated with smoking.

In this fast and fanciful look forward, one should not leave out the inevitable resurgence of large-scale cultivation and production of fiber hemp: a versatile, ecologically sustainable plant with more than 25,000 known industrial applications—from hemp clothing, cosmetics and foods (hemp seeds are a powerful source of protein) to oil-free plastics, hemp surfboards, insulation, and car panels.

Practically speaking, CBD, what Robert Louis Stevenson called “golden oil,” is but a byproduct of the non-psychoactive hemp plant. Thousands of industrial hemp farms are stripping CBD-rich leaves and stems from the desired fiber and composting them. It’s reasonable to suppose that the tragedy of losing all that medical value for victims of cancer and other maladies will not be lost on those who follow us.

If the cannabis plant hasn’t done enough for us, providing wellness for the body and change for the mind, it can also help us pull the petroleum out of our economic jugular, possibly giving rise to a healthier, vegetable-based, organic life-support system for our children.

Allan Badiner is a writer, activist and editor of three books: DHARMA GAIA: A HARVEST OF ESSAYS ON BUDDHISM & ECOLOGY, ZIG ZAG ZEN: BUDDHISM & PSYCHEDELICS, and MINDFULNESS IN THE MARKETPLACE: COMPASSIONATE RESPONSES TO CONSUMERISM. The above article originally appeared at Reality Sandwich.